Anupam Rasayan India Ltd engages in the custom synthesis and manufacturing of specialty chemicals in India, Europe, Japan, Singapore, China, North America, and internationally. It operates through two segments: Life Science related Specialty Chemicals and Other Specialty Chemicals. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultraviolet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It provides other specialty chemicals used in various end-user segments, including specialty pigments, specialty dyes, and polymer additives. The company was incorporated in 1984 and is headquartered in Surat, India.
Revenue projections:
Revenue projections for ANURAS Revenues for ANURAS are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.
Financial Ratios:
currentRatio
1.42300
forwardPE
37.81479
debtToEquity
44.56600
earningsGrowth
0.44700
revenueGrowth
0.24700
grossMargins
0.57933
operatingMargins
0.22752
trailingEps
8.52000
forwardEps
21.98000
ANURAS's current ratio, being 1.423, demonstrates that the company has the liquidity necessary to service its short-term debt. With strong cash reserves and current assets, ANURAS is well-equipped to meet its immediate financial obligations without any difficulties. Anupam Rasayan India Ltd's positive earnings and revenue growth indicate that the company is on track to expand its business. This growth suggests a strong financial outlook, with increasing profits and sales positioning Anupam Rasayan India Ltd for continued success in the market. Anupam Rasayan India Ltd's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness. Anupam Rasayan India Ltd's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting Anupam Rasayan India Ltd to generate stronger earnings compared to the previous financial year.
Price projections:
Price projections for ANURAS Price projections for ANURAS have been revised down over time, reflecting a less optimistic outlook. Analysts appear to be adjusting their expectations, signaling concerns about the company's ability to sustain its previous growth levels.
ANURAS's price has already surpassed the upper threshold of projections, indicating significant upward momentum. However, the constrained potential for further increases suggests that the stock may be reaching a point of stabilization.
Recommendation changes over time:
Recommendations trend for ANURAS
Analysts have recently shown a sell bias for ANURAS, signaling a need for caution. Investors should not rely solely on this sentiment but instead consider a variety of market indicators to make more informed decisions about the stock's future prospects and potential risks.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article analyzes the recently announced 5% remittance tax by the Trump...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.